|
28 Jul 2021 |
AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity
|
|
27 Jul 2021 |
Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant (OBE022), an Investigational Agent Being Evaluated as a First-in-Class Treatment for Preterm Labor
|
|
22 Jul 2021 |
Mirimus, Inc. Forms Strategic Collaboration with Biogen to Develop RNAi-Based Therapeutics for Neurological Disease Indications
|
|
21 Jul 2021 |
NanoSyrinx raises £6.2m to develop its synthetic biology platform for targeted intracellular engineering
|
|
20 Jul 2021 |
Junshi Biosciences and Immorna Announce Joint Venture to Develop Innovative Self-Replicating and Conventional mRNA Therapeutics and Vaccines
|
|
19 Jul 2021 |
Successful anti-cancer alliance extended
|
|
17 Jul 2021 |
GC LabCell and GC Cell to Merge, Creating a Premier Cell Therapy Company
|
|
16 Jul 2021 |
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
|
|
15 Jul 2021 |
PAQ Therapeutics Launches with $30 Million Series A to Develop Novel Therapies through Autophagy-Dependent Degradation
|
|
15 Jul 2021 |
Lilly Announces Acquisition of Protomer Technologies
|
|
13 Jul 2021 |
ExCellThera and Astellas enter into a license for the use of molecule UM171 in the field of pluripotent stem cells
|
|
13 Jul 2021 |
eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement
|
|
13 Jul 2021 |
48Hour Discovery and RayzeBio Announce Strategic Research Collaboration to Discover & Develop Novel Peptide-Based Radiopharmaceuticals
|
|
13 Jul 2021 |
Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technology
|
|
13 Jul 2021 |
Biogen and Innocare Announce License and Collaboration Agreement For Orelabrutinib, an Innovative CNS Penetrant BTK Inhibitor For the Potential Treatment of Multiple Sclerosis
|
|
13 Jul 2021 |
Servier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics
|
|
13 Jul 2021 |
Prothena and Novo Nordisk announce acquisition agreement for Prothena’s ATTR amyloidosis programme
|
|
09 Jul 2021 |
I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms
|
|
09 Jul 2021 |
Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
|
|
09 Jul 2021 |
Verge Genomics Announces Three-Year Collaboration With Lilly to Discover and Develop Novel Treatments Using Its AI-Driven All-in-Human Platform
|
|
09 Jul 2021 |
F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors
|
|
06 Jul 2021 |
Eureka Therapeutics Announces New GPRC5D License Agreement with Sanofi to Target Multiple Myeloma
|
|
06 Jul 2021 |
South-Korean biotech Y-Biologics and French mid-pharma Pierre Fabre enter into a worldwide exclusive license agreement in the highly innovative field of immuno-oncology
|
|
06 Jul 2021 |
Sosei Heptares and InveniAI Enter a Multi-target AI-powered and GPCR-focused Drug Discovery Collaboration
|
|
02 Jul 2021 |
Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206
|
